The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Neostem Inc.  (NBS) Trade Now »     Rate NBS  -  Discuss NBS  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Healthcare Facilities
SocialPicks Sentiment:
N/A

** not enough data to be rated 		This Quarter's Sentiment:
All:
100.0%
Top:
100.0%
Rate NBS:


Home
Analysis & Videos
Quotes
Bull or Bear
Discuss
        

NBS: Bull or Bear? From:    SocialPicks  |  Blogsphere  |  All

SocialPicks Community

NeoStem (AMEX:NBS): BusinessWeek Mention Graphic_rating_buy NBS
Mikerun
73%
 
<font> NeoStem, Inc. </font> (AMEX:NBS)is a pioneer and leader in the pre-disease collection, processing and long-term storage of adult stem cells for the general population to use in future medical applications. The Company's business model includes generating revenue through ongoing fees associated with a minimally invasive, proprietary stem cell collection process, in addition to fees charged to the centers for marketing and long-term storage.
 
<> The Company was recently <font> profiled at BusinessWeek online </font> and will appear in the June 29 pr...
By  Mike Havrilla   (+1.04%  risk: conservative)  06/19/09 Comment


NeoStem (AMEX:NBS): Pro-Active Research Initiates as Spec Buy Graphic_rating_buy NBS
Mikerun
73%
 
<> <font> NeoStem, Inc. </font> (AMEX:NBS)is a pioneer and leader in the pre-disease collection, processing and long-term storage of adult stem cells for the general population to use in future medical applications. The Company's business model includes generating revenue through ongoing fees associated with a minimally invasive, proprietary stem cell collection process, in addition to fees charged to the centers for marketing and long-term storage. NeoStem targets its marketing efforts toward health conscious consumers to encourage them to donate and store their stem cell...
By  Mike Havrilla   (+1.04%  risk: conservative)  06/04/09 Comment


NeoStem Expands Beyond Stem Cell Banking Graphic_rating_buy NBS
Mikerun
73%
 
<> NeoStem (AMEX:NBS) is a pioneer and leader in the pre-disease collection, processing and long-term storage of adult stem cells for the general population to use in future medical applications. The Company's business model includes generating revenue through ongoing fees associated with a minimally invasive, proprietary stem cell collection process, in addition to fees charged to the centers for marketing and long-term storage. NeoStem targets its marketing efforts toward health conscious consumers to encourage them to donate and store their stem cells as a form of bio-insuran...
By  Mike Havrilla   (+1.04%  risk: conservative)  05/18/09 Comment


Stem Cell Index Surges in Past Week Graphic_rating_buy NBS
Mikerun
73%
<> The stem cell trade was back in a big way over the past week, with several stocks in the <font> ETF Innovators Stem Cell Index </font> registering impressive gains, compared to market and biotech ETF benchmarks such as the S&P 500 SPDR (NYSE:SPY) +6%, iShares Nasdaq Biotech (NASDAQ:IBB) +2%, SPDR S&P Biotech (NYSE:XBI +4%). Hot stocks over the past week among the 40 component companies in the stem cell index include NeoStem (AMEX:NBS) +52.2%, Cytori Therapeutics (NASDAQ:CYTX) +37%, and Geron (NASDAQ:GERN) +22%. Two other widely followed stocks from the index registered smaller gains,...
By  Mike Havrilla   (+1.04%  risk: conservative)  05/10/09 Comment


Stem Cell Index: YTD Analysis, Banking on NeoStem Graphic_rating_buy NBS
Mikerun
73%
Related Tickers: NBS, IART, OSIR, STEM, GE, XLV, IBB, XBI, PBE, SPY
By Mike Havrilla on 4/11/09 at www.BioMedReports.com
Disclosure: No Positions
 
The ETF Innovators Global Stem Cell and Regenerative Medicine Index tracks the performance of 40 stem cell and regenerative medicine companies on a global basis with market caps of less than $1 billion at the inception of the index. The total market value of the index will be tracked as a gauge of investor and trader sentiment toward stem cell companies from a starting value of 3,928 on 2/22/09.
 
...
By  Mike Havrilla   (+1.04%  risk: conservative)  04/11/09 Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.44% 381
2 Gerald Greene 18.14 +71.24% 211
3 stockmarketfunding.com 17.66 +25.60% 55
4 akiralegrand 13.47 +14.32% 62
5 anup2104 12.13 +74.22% 40


POPULAR STOCKS
Symbol Company Name Sentiment
YHOO Yahoo! Inc
MSFT Microsoft Corp
EBAY eBay Inc
C Citigroup Inc
PG The Procter & Gamble Company
RIO Companhia Vale Do Rio Doce

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on NBS

Visit streetinsider.com


Discussion Wall + Add  

Be the first to start a discussion and earn 2 points.



More Resources

Graphic_arrow1 About Neostem Inc. - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch